spacer
home > ebr > winter 2003 > e-meetings and e-learning - how the internet can be harnessed to achieve efficiencies in clinical drug development
PUBLICATIONS
European Biopharmaceutical Review

e-Meetings and e-Learning - How the Internet can be Harnessed to Achieve Efficiencies in Clinical Drug Development

Driven by a need to reduce drug development costs and speed new drugs to market in the most efficient manner possible, today's pharma industry is awash with cost containment measures. Senior executives continue the search for elusive efficiencies, ranging from the overnight closure of departments that were previously considered integral to a company's success to the imposition of strict new travel policies. Few pharmaceutical companies or contract research organisations can have been immune to cost cutting in recent years and many have looked to the promise of technology to help them achieve their goals.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Jane Baguley, Director at Cornaxis Ltd

With an Honours degree in Cell Sciences, Jane Baguley joined the pharmaceutical industry in 1988. After five years with Yamanouchi Pharma, Jane began a varied career at Quintiles encompassing both operational and business roles including clinical project management, medical writing, communication and strategy and business management. At the beginning of 2002, Jane set up Cornaxis Ltd to provide consultancy, strategic and operational services to the pharma industry. Cornaxis focuses on the use of novel technologies to support the attainment of cost efficiencies in the drug development process, while Jane maintains a particular interest in the challenge of patient recruitment.

spacer
Jane Baguley
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PPMA Group Industry Awards 2019

PPMA Group is today issuing a ‘Final Call for Entries’ to the 2019 PPMA Group Industry Awards. All companies within the packaging and processing sector are invited to submit their FREE submission by the deadline of 17 July 2019.
More info >>

White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

 
Industry Events

CPhI Korea

21-23 August 2019, COEX, Seoul, South Korea

CPhI Korea provides a dynamic meeting place for a wide range of industry suppliers to engage with purchasers and decision makers from the pharmaceutical industry in Korea and the surrounding region. The exhibition showcases the whole pharma supply chain from ingredients, contracting services to machinery and biopharmaceuticals. It also hosts an extensive conference programme covering the latest trends and topics within the regional market.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement